Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine
ABSTRACT Plasmalogens are natural glycerophospholipids that account for approximately 15%–20% (mol%) of human tissues' cellular membrane phospholipid composition. They play an important role in lipid membrane organization and function, including acting as endogenous antioxidants. Plasmalogens c...
Saved in:
| Main Authors: | Yu Wu, Yuru Deng, Borislav Angelov, Angelina Angelova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | FASEB BioAdvances |
| Subjects: | |
| Online Access: | https://doi.org/10.1096/fba.2025-00010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of protein-lipid comlex by its fatty acid and vitamin composition
by: B. A. Bazhenova, et al.
Published: (2021-07-01) -
Bioengineered microneedles and nanomedicine as therapeutic platform for tissue regeneration
by: Yi-an Mao, et al.
Published: (2025-08-01) -
Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases
by: Lin X, et al.
Published: (2025-07-01) -
Nanomedicines in the Treatment of Liver Fibrosis: A Review
by: Du X, et al.
Published: (2025-08-01) -
Antiviral nanomedicine: Advantages, mechanisms and advanced therapies
by: Yicheng Pu, et al.
Published: (2025-10-01)